- Current report filing (8-K)

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

---

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

---

 

Date of report (Date of earliest event reported) October 14, 2009

 

deCODE genetics, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware		000-30469		04-3326704
(State or Other Jurisdiction		(Commission		(I.R.S. Employer
of Incorporation)		File Number)		Identification No.)

 

Sturlugata 8, IS-101 Reykjavik, Iceland

(Address of Principal Executive Offices)

 

Registrant’s telephone number, including area code [phone]

 

 

(Former Name or Former Address, If Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o     Written communications pursuant to Rule 425 under the Securities Act

 

o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

 

 

---

 

Item 8.01       Other Events

 

deCODE genetics, Inc. (“deCODE”) will not make the scheduled October 15 interest payment on its outstanding 3.5% Convertible Notes due 2011.   Failure to pay such interest within thirty (30) days after October 15 would be an event of default under the terms of the indentures securing the notes.

 

2

---

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

	deCODE genetics, Inc.
	By:	/s/ KARI STEFANSSON
		Kari Stefansson
		President and Chief Executive Officer
Dated: October 14, 2009

 

3

---